Abstract:Histone deacetylases constitute a group of enzymes that participate in several biological processes. Notably, inhibiting HDAC8 has become a therapeutic strategy for various diseases. The current inhibitors for HDAC8 lack selectivity and target multiple HDACs. Consequently, there is a growing recognition of the need for selective HDAC8 inhibitors to enhance the effectiveness of therapeutic interventions. In our current study, we have utilized a multi-faceted approach, including Quantitative Structure–Activity Relationship (QSAR) combined with Quantitative Read-Across Structure–Activity Relationship (q-RASAR) modeling, pharmacophore mapping, molecular docking, and molecular dynamics (MD) simulations. The developed q-RASAR model has a high statistical significance and predictive ability ( Q 2 F1 :0.778, Q 2 F2 :0.775). The contributions of important descriptors are discussed in detail to gain insight into the crucial structural features in HDAC8 inhibition. The best pharmacophore hypothesis exhibits a high regression coefficient (0.969) and a low root mean square deviation (0.944), highlighting the importance of correctly orienting hydrogen bond acceptor (HBA), ring aromatic (RA), and zinc-binding group (ZBG) features in designing potent HDAC8 inhibitors. To confirm the results of q-RASAR and pharmacophore mapping, molecular docking analysis of the five potent compounds ( 44 , 54 , 82 , 102, and 118 ) was performed to gain further insights into these structural features crucial for interaction with the HDAC8 enzyme. Lastly, MD simulation studies of the most active compound ( 54 , mapped correctly with the pharmacophore hypothesis) and the least active compound ( 34 , mapped poorly with the pharmacophore hypothesis) were carried out to validate the observations of the studies above. This study not only refines our understanding of essential structural features for HDAC8 inhibition but also provides a robust framework for the rational design of novel selective HDAC8 inhibitors which may offer insights to medicinal chemists and researchers engaged in the development of HDAC8-targeted therapeutics.

Quantitative Structure-Activity Relationship Study of Amino Acid Derivatives as Histone Deacetylase Inhibitors using the Genetic Algorithm – Multiple Linear Regression

Quantitative Structure-Activity Relationship Study of Histone Deacetylase Inhibitors.

Quantitative Structure-Activity Relationship Analysis of the Anticonvulsant Activity of Some Benzylacetamides Based on Genetic Algorithm-Based Multiple Linear Regression

Quantitative structure–activity relationship (QSAR) study of interleukin-1 receptor associated kinase 4 (IRAK-4) inhibitor activity by the genetic algorithm and multiple linear regression (GA-MLR) method

Predictive QSAR Models of 3-Acylamino-2-aminopropionic Acid Derivatives As Partial Agonists of the Glycine Site on the NMDA Receptor

Harmonizing QSAR Machine Learning‐Based Models and Docking Approaches for Identifying Novel Histone Deacetylase 2 Inhibitors

QSAR Models for Predicting Aquatic Toxicity of Esters Using Genetic Algorithm-Multiple Linear Regression Methods

Exploring different classification-dependent QSAR modelling strategies for HDAC3 inhibitors in search of meaningful structural contributors

Screening of Selective Histone Deacetylase Inhibitors by Proteochemometric Modeling

Exploration of Fingerprints and Data Mining-based Prediction of Some Bioactive Compounds from Allium sativum as Histone Deacetylase 9 (HDAC9) Inhibitors

Applications of genetic algorithms on the structure-activity relationship analysis of some cinnamamides.

Applications of Genetic Algorithms on the Structure–activity Correlation Study of a Group of Non-Nucleoside HIV-1 Inhibitors

A quantitative structural analysis of AR-42 derivatives as HDAC1 inhibitors for the identification of promising structural contributors

Using Support Vector Regression Coupled with the Genetic Algorithm for Predicting Acute Toxicity to the Fathead Minnow

Molecular Bioactivity Prediction of HDAC1: Based on Deep Neural Nets

Unveiling critical structural features for effective HDAC8 inhibition: a comprehensive study using quantitative read-across structure–activity relationship (q-RASAR) and pharmacophore modeling

Quantitative Structure–activity Relationship Study of Influenza Virus Neuraminidase A/PR/8/34 (H1N1) Inhibitors by Genetic Algorithm Feature Selection and Support Vector Regression

Quantitative structure/activity relationship modelling of pharmacokinetic properties using genetic algorithm-combined partial least squares method

Homology modeling, force field design, and free energy simulation studies to optimize the activities of histone deacetylase inhibitors

QSAR Regression Models for Predicting HMG-CoA Reductase Inhibition

Quantitative Structure–Activity Relationship Evaluation of MDA-MB-231 Cell Anti-Proliferative Leads